Anthony B. Evnin, Director at AVEO PHARMACEUTICALS INC (AVEO), bought 109 shares at $2.05 ($223) on 2018-11-21, disclosed to the SEC on 2018-11-26.
Open-market purchase of $223 AVEO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |
| CNST | BUY | 2018-07-23 | $2.0M | — | Filing → |